{"transactions":[{"id":3823,"issuer":{"id":2545,"kind":"organization","name":"Fulgent Genetics, Inc.","symbol":"FLGT"},"owners":[{"id":2548,"kind":"person","name":"Gao Hanlin","position":1,"cik":"0001684532","reported_name":"Gao Hanlin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2026-09-03T23:47:39.000Z","date":"2026-09-02","kind":"sale","planned":false,"acquired":false,"shares":1673,"price":19.6564,"value":32885.1572,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were sold by the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units granted to the reporting person on February 25, 2025, which grant was originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on February 27, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The shares were sold in multiple transactions at prices ranging from $19.60 to $19.74, inclusive. The reported price reflects the weighted-average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected."}],"balance_after":986117,"source":{"system":"sec-edgar","filing":"0001684532-26-000013","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1684532/000168453226000013/ownership.xml","form_type":"4"}},{"id":672964,"issuer":{"id":2545,"kind":"organization","name":"Fulgent Genetics, Inc.","symbol":"FLGT"},"owners":[{"id":2548,"kind":"person","name":"Gao Hanlin","position":1,"cik":"0001684532","reported_name":"Gao Hanlin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2026-08-28T22:05:20.000Z","date":"2026-08-27","kind":"sale","planned":false,"acquired":false,"shares":939,"price":19.9053,"value":18691.0767,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were sold by the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units granted to the reporting person on February 26, 2024, which grant was originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on February 28, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The shares were sold in multiple transactions at prices ranging from $19.83 to $20.00, inclusive. The reported price reflects the weighted-average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected."}],"balance_after":987790,"source":{"system":"sec-edgar","filing":"0001684532-26-000009","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1684532/000168453226000009/ownership.xml","form_type":"4"}},{"id":702197,"issuer":{"id":2545,"kind":"organization","name":"Fulgent Genetics, Inc.","symbol":"FLGT"},"owners":[{"id":2548,"kind":"person","name":"Gao Hanlin","position":1,"cik":"0001684532","reported_name":"Gao Hanlin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2026-07-28T20:32:03.000Z","date":"2026-07-26","kind":"tax_withholding","planned":false,"acquired":false,"shares":1645,"price":19.67,"value":32357.15,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units assumed pursuant to the Agreement and Plan of Merger, dated as of November 7, 2022 by and among Fulgent Genetics, Inc., FG Merger Sub, Inc., Fulgent Pharma Holdings, Inc., and the stockholders listed therein. These awards were originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on November 9, 2022."}],"balance_after":988729,"source":{"system":"sec-edgar","filing":"0001193125-26-321085","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1684532/000119312526321085/ownership.xml","form_type":"4"}},{"id":751761,"issuer":{"id":2545,"kind":"organization","name":"Fulgent Genetics, Inc.","symbol":"FLGT"},"owners":[{"id":2548,"kind":"person","name":"Gao Hanlin","position":1,"cik":"0001684532","reported_name":"Gao Hanlin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2026-06-03T21:29:37.000Z","date":"2026-06-02","kind":"sale","planned":false,"acquired":false,"shares":1688,"price":17.8855,"value":30190.724,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were sold by the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units granted to the reporting person on February 25, 2025, which grant was originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on February 27, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The shares were sold in multiple transactions at prices ranging from $17.63 to $18.10, inclusive. The reported price reflects the weighted-average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected."}],"balance_after":990374,"source":{"system":"sec-edgar","filing":"0001684532-26-000005","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1684532/000168453226000005/ownership.xml","form_type":"4"}},{"id":760208,"issuer":{"id":2545,"kind":"organization","name":"Fulgent Genetics, Inc.","symbol":"FLGT"},"owners":[{"id":2548,"kind":"person","name":"Gao Hanlin","position":1,"cik":"0001684532","reported_name":"Gao Hanlin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2026-05-28T21:19:46.000Z","date":"2026-05-27","kind":"sale","planned":false,"acquired":false,"shares":945,"price":17.6,"value":16632.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were sold by the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units granted to the reporting person on February 26, 2024, which grant was originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on February 28, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The shares were sold in multiple transactions at prices ranging from $17.39 to $17.76, inclusive. The reported price reflects the weighted-average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected."}],"balance_after":992062,"source":{"system":"sec-edgar","filing":"0001684532-26-000003","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1684532/000168453226000003/ownership.xml","form_type":"4"}},{"id":798848,"issuer":{"id":2545,"kind":"organization","name":"Fulgent Genetics, Inc.","symbol":"FLGT"},"owners":[{"id":2548,"kind":"person","name":"Gao Hanlin","position":1,"cik":"0001684532","reported_name":"Gao Hanlin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2026-04-28T20:52:14.000Z","date":"2026-04-26","kind":"tax_withholding","planned":false,"acquired":false,"shares":1645,"price":16.31,"value":26829.95,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units assumed pursuant to the Agreement and Plan of Merger, dated as of November 7, 2022 by and among Fulgent Genetics, Inc., FG Merger Sub, Inc., Fulgent Pharma Holdings, Inc., and the stockholders listed therein. These awards were originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on November 9, 2022."}],"balance_after":993007,"source":{"system":"sec-edgar","filing":"0001193125-26-187451","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1684532/000119312526187451/ownership.xml","form_type":"4"}},{"id":874175,"issuer":{"id":2545,"kind":"organization","name":"Fulgent Genetics, Inc.","symbol":"FLGT"},"owners":[{"id":2548,"kind":"person","name":"Gao Hanlin","position":1,"cik":"0001684532","reported_name":"Gao Hanlin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2026-03-03T01:00:47.000Z","date":"2026-03-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":6410,"price":15.33,"value":98265.3,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units granted to the reporting person on February 25, 2025, which grant was originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on February 27, 2025."}],"balance_after":994652,"source":{"system":"sec-edgar","filing":"0001684532-26-000001","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1684532/000168453226000001/ownership.xml","form_type":"4"}},{"id":874174,"issuer":{"id":2545,"kind":"organization","name":"Fulgent Genetics, Inc.","symbol":"FLGT"},"owners":[{"id":2548,"kind":"person","name":"Gao Hanlin","position":1,"cik":"0001684532","reported_name":"Gao Hanlin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2026-03-03T01:00:47.000Z","date":"2026-03-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":1018,"price":15.33,"value":15605.94,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units granted to the reporting person on February 28, 2022, which grant was originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on March 2, 2022."}],"balance_after":1001062,"source":{"system":"sec-edgar","filing":"0001684532-26-000001","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1684532/000168453226000001/ownership.xml","form_type":"4"}},{"id":874173,"issuer":{"id":2545,"kind":"organization","name":"Fulgent Genetics, Inc.","symbol":"FLGT"},"owners":[{"id":2548,"kind":"person","name":"Gao Hanlin","position":1,"cik":"0001684532","reported_name":"Gao Hanlin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2026-03-03T01:00:47.000Z","date":"2026-02-26","kind":"tax_withholding","planned":false,"acquired":false,"shares":897,"price":24.76,"value":22209.72,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units granted to the reporting person on February 26, 2024, which grant was originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on February 28, 2024."}],"balance_after":1002080,"source":{"system":"sec-edgar","filing":"0001684532-26-000001","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1684532/000168453226000001/ownership.xml","form_type":"4"}},{"id":882020,"issuer":{"id":2545,"kind":"organization","name":"Fulgent Genetics, Inc.","symbol":"FLGT"},"owners":[{"id":2548,"kind":"person","name":"Gao Hanlin","position":1,"cik":"0001684532","reported_name":"Gao Hanlin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2026-02-26T01:17:59.000Z","date":"2026-02-24","kind":"grant","planned":false,"acquired":true,"shares":26661,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F8","text":"Restricted stock units. The shares subject to the restricted stock units vest over a period of three years, with 1/3rd of such shares vesting 12 months after March 1, 2026, and 1/12th of such shares vesting at the end of every three-month period thereafter over the remaining 24 months, subject to continued service for Issuer on each vesting date."}],"balance_after":1002977,"source":{"system":"sec-edgar","filing":"0001193125-26-072639","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1684532/000119312526072639/ownership.xml","form_type":"4"}},{"id":882019,"issuer":{"id":2545,"kind":"organization","name":"Fulgent Genetics, Inc.","symbol":"FLGT"},"owners":[{"id":2548,"kind":"person","name":"Gao Hanlin","position":1,"cik":"0001684532","reported_name":"Gao Hanlin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2026-02-26T01:17:59.000Z","date":"2026-02-24","kind":"tax_withholding","planned":false,"acquired":false,"shares":8149,"price":23.09,"value":188160.41,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F7","text":"The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of the above performance-based restricted stock units granted to the reporting person on February 25, 2025."}],"balance_after":976316,"source":{"system":"sec-edgar","filing":"0001193125-26-072639","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1684532/000119312526072639/ownership.xml","form_type":"4"}},{"id":882018,"issuer":{"id":2545,"kind":"organization","name":"Fulgent Genetics, Inc.","symbol":"FLGT"},"owners":[{"id":2548,"kind":"person","name":"Gao Hanlin","position":1,"cik":"0001684532","reported_name":"Gao Hanlin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2026-02-26T01:17:59.000Z","date":"2026-02-24","kind":"tax_withholding","planned":false,"acquired":false,"shares":4661,"price":23.09,"value":107622.49,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F6","text":"The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of the above performance-based restricted stock units granted to the reporting person on February 26, 2024."}],"balance_after":984465,"source":{"system":"sec-edgar","filing":"0001193125-26-072639","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1684532/000119312526072639/ownership.xml","form_type":"4"}},{"id":882017,"issuer":{"id":2545,"kind":"organization","name":"Fulgent Genetics, Inc.","symbol":"FLGT"},"owners":[{"id":2548,"kind":"person","name":"Gao Hanlin","position":1,"cik":"0001684532","reported_name":"Gao Hanlin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2026-02-26T01:17:59.000Z","date":"2026-02-24","kind":"tax_withholding","planned":false,"acquired":false,"shares":2489,"price":23.09,"value":57471.01,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F5","text":"The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of the above performance-based restricted stock units granted to the reporting person on February 23, 2023."}],"balance_after":989126,"source":{"system":"sec-edgar","filing":"0001193125-26-072639","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1684532/000119312526072639/ownership.xml","form_type":"4"}},{"id":882016,"issuer":{"id":2545,"kind":"organization","name":"Fulgent Genetics, Inc.","symbol":"FLGT"},"owners":[{"id":2548,"kind":"person","name":"Gao Hanlin","position":1,"cik":"0001684532","reported_name":"Gao Hanlin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2026-02-26T01:17:59.000Z","date":"2026-02-24","kind":"grant","planned":false,"acquired":true,"shares":22806,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"Performance-based restricted stock units. The shares vested pursuant to certain performance milestones for performance-based restricted stock units granted on February 25, 2025."}],"balance_after":991615,"source":{"system":"sec-edgar","filing":"0001193125-26-072639","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1684532/000119312526072639/ownership.xml","form_type":"4"}},{"id":882015,"issuer":{"id":2545,"kind":"organization","name":"Fulgent Genetics, Inc.","symbol":"FLGT"},"owners":[{"id":2548,"kind":"person","name":"Gao Hanlin","position":1,"cik":"0001684532","reported_name":"Gao Hanlin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2026-02-26T01:17:59.000Z","date":"2026-02-24","kind":"grant","planned":false,"acquired":true,"shares":12762,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Performance-based restricted stock units. The shares vested pursuant to certain performance milestones for performance-based restricted stock units granted on February 26, 2024."}],"balance_after":968809,"source":{"system":"sec-edgar","filing":"0001193125-26-072639","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1684532/000119312526072639/ownership.xml","form_type":"4"}},{"id":882014,"issuer":{"id":2545,"kind":"organization","name":"Fulgent Genetics, Inc.","symbol":"FLGT"},"owners":[{"id":2548,"kind":"person","name":"Gao Hanlin","position":1,"cik":"0001684532","reported_name":"Gao Hanlin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2026-02-26T01:17:59.000Z","date":"2026-02-24","kind":"grant","planned":false,"acquired":true,"shares":4891,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Performance-based restricted stock units. The shares vested pursuant to certain performance milestones for performance-based restricted stock units granted on February 23, 2023."}],"balance_after":956047,"source":{"system":"sec-edgar","filing":"0001193125-26-072639","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1684532/000119312526072639/ownership.xml","form_type":"4"}},{"id":882013,"issuer":{"id":2545,"kind":"organization","name":"Fulgent Genetics, Inc.","symbol":"FLGT"},"owners":[{"id":2548,"kind":"person","name":"Gao Hanlin","position":1,"cik":"0001684532","reported_name":"Gao Hanlin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2026-02-26T01:17:59.000Z","date":"2026-02-23","kind":"tax_withholding","planned":false,"acquired":false,"shares":403,"price":23.01,"value":9273.03,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units granted to the reporting person on February 23, 2023, which grant was originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on February 27, 2023."}],"balance_after":951156,"source":{"system":"sec-edgar","filing":"0001193125-26-072639","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1684532/000119312526072639/ownership.xml","form_type":"4"}},{"id":928965,"issuer":{"id":2545,"kind":"organization","name":"Fulgent Genetics, Inc.","symbol":"FLGT"},"owners":[{"id":2548,"kind":"person","name":"Gao Hanlin","position":1,"cik":"0001684532","reported_name":"Gao Hanlin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2026-01-28T22:02:27.000Z","date":"2026-01-26","kind":"tax_withholding","planned":false,"acquired":false,"shares":1331,"price":27.53,"value":36642.43,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units assumed pursuant to the Agreement and Plan of Merger, dated as of November 7, 2022 by and among Fulgent Genetics, Inc., FG Merger Sub, Inc., Fulgent Pharma Holdings, Inc., and the stockholders listed therein. These awards were originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on November 9, 2022."}],"balance_after":951559,"source":{"system":"sec-edgar","filing":"0001193125-26-027405","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1684532/000119312526027405/ownership.xml","form_type":"4"}},{"id":981544,"issuer":{"id":2545,"kind":"organization","name":"Fulgent Genetics, Inc.","symbol":"FLGT"},"owners":[{"id":2548,"kind":"person","name":"Gao Hanlin","position":1,"cik":"0001684532","reported_name":"Gao Hanlin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2025-12-03T22:04:22.000Z","date":"2025-12-02","kind":"sale","planned":false,"acquired":false,"shares":1075,"price":28.3318,"value":30456.685,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were sold by the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units granted to the reporting person on February 28, 2022, which grant was originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on March 2, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The shares were sold in multiple transactions at prices ranging from $28.27 to $28.38, inclusive. The reported price reflects the weighted-average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected."}],"balance_after":952890,"source":{"system":"sec-edgar","filing":"0001193125-25-306920","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1684532/000119312525306920/ownership.xml","form_type":"4"}},{"id":985103,"issuer":{"id":2545,"kind":"organization","name":"Fulgent Genetics, Inc.","symbol":"FLGT"},"owners":[{"id":2548,"kind":"person","name":"Gao Hanlin","position":1,"cik":"0001684532","reported_name":"Gao Hanlin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2025-12-02T02:14:37.000Z","date":"2025-11-28","kind":"sale","planned":false,"acquired":false,"shares":943,"price":29.5695,"value":27884.0385,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were sold by the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units granted to the reporting person on February 26, 2024, which grant was originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on February 28, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The shares were sold in multiple transactions at prices ranging from $29.45 to $29.67, inclusive. The reported price reflects the weighted-average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected."}],"balance_after":953965,"source":{"system":"sec-edgar","filing":"0001193125-25-304293","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1684532/000119312525304293/ownership.xml","form_type":"4"}},{"id":988716,"issuer":{"id":2545,"kind":"organization","name":"Fulgent Genetics, Inc.","symbol":"FLGT"},"owners":[{"id":2548,"kind":"person","name":"Gao Hanlin","position":1,"cik":"0001684532","reported_name":"Gao Hanlin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2025-11-25T21:30:03.000Z","date":"2025-11-24","kind":"sale","planned":false,"acquired":false,"shares":535,"price":30.473,"value":16303.055,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were sold by the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units granted to the reporting person on February 23, 2023, which grant was originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on February 27, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The shares were sold in multiple transactions at prices ranging from $30.33 to $30.62, inclusive. The reported price reflects the weighted-average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected."}],"balance_after":954908,"source":{"system":"sec-edgar","filing":"0001193125-25-297321","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1684532/000119312525297321/ownership.xml","form_type":"4"}},{"id":1012588,"issuer":{"id":2545,"kind":"organization","name":"Fulgent Genetics, Inc.","symbol":"FLGT"},"owners":[{"id":2548,"kind":"person","name":"Gao Hanlin","position":1,"cik":"0001684532","reported_name":"Gao Hanlin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2025-10-28T21:20:27.000Z","date":"2025-10-26","kind":"tax_withholding","planned":false,"acquired":false,"shares":1642,"price":23.74,"value":38981.08,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units assumed pursuant to the Agreement and Plan of Merger, dated as of November 7, 2022 by and among Fulgent Genetics, Inc., FG Merger Sub, Inc., Fulgent Pharma Holdings, Inc., and the stockholders listed therein. These awards were originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on November 9, 2022."}],"balance_after":955443,"source":{"system":"sec-edgar","filing":"0001193125-25-253873","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1684532/000119312525253873/ownership.xml","form_type":"4"}},{"id":1049638,"issuer":{"id":2545,"kind":"organization","name":"Fulgent Genetics, Inc.","symbol":"FLGT"},"owners":[{"id":2548,"kind":"person","name":"Gao Hanlin","position":1,"cik":"0001684532","reported_name":"Gao Hanlin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2025-09-03T21:33:19.000Z","date":"2025-09-03","kind":"sale","planned":false,"acquired":false,"shares":1063,"price":22.0267,"value":23414.3821,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were sold by the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units granted to the reporting person on February 28, 2022, which grant was originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on March 2, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The shares were sold in multiple transactions at prices ranging from $21.92 to $22.175, inclusive. The reported price reflects the weighted-average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected."}],"balance_after":957085,"source":{"system":"sec-edgar","filing":"0001684532-25-000014","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1684532/000168453225000014/ownership.xml","form_type":"4"}},{"id":1053615,"issuer":{"id":2545,"kind":"organization","name":"Fulgent Genetics, Inc.","symbol":"FLGT"},"owners":[{"id":2548,"kind":"person","name":"Gao Hanlin","position":1,"cik":"0001684532","reported_name":"Gao Hanlin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2025-08-28T22:55:08.000Z","date":"2025-08-27","kind":"sale","planned":false,"acquired":false,"shares":943,"price":21.4847,"value":20260.0721,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were sold by the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units granted to the reporting person on February 26, 2024, which grant was originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on February 28, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The shares were sold in multiple transactions at prices ranging from $21.28 to $21.66, inclusive. The reported price reflects the weighted-average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected."}],"balance_after":958148,"source":{"system":"sec-edgar","filing":"0001684532-25-000010","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1684532/000168453225000010/ownership.xml","form_type":"4"}},{"id":1055689,"issuer":{"id":2545,"kind":"organization","name":"Fulgent Genetics, Inc.","symbol":"FLGT"},"owners":[{"id":2548,"kind":"person","name":"Gao Hanlin","position":1,"cik":"0001684532","reported_name":"Gao Hanlin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2025-08-26T23:10:51.000Z","date":"2025-08-25","kind":"sale","planned":false,"acquired":false,"shares":548,"price":21.5016,"value":11782.8768,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were sold by the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units granted to the reporting person on February 23, 2023, which grant was originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on February 27, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The shares were sold in multiple transactions at prices ranging from $21.46 to $21.57, inclusive. The reported price reflects the weighted-average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected."}],"balance_after":959091,"source":{"system":"sec-edgar","filing":"0001684532-25-000005","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1684532/000168453225000005/ownership.xml","form_type":"4"}},{"id":1079802,"issuer":{"id":2545,"kind":"organization","name":"Fulgent Genetics, Inc.","symbol":"FLGT"},"owners":[{"id":2548,"kind":"person","name":"Gao Hanlin","position":1,"cik":"0001684532","reported_name":"Gao Hanlin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2025-07-29T22:04:05.000Z","date":"2025-07-26","kind":"tax_withholding","planned":false,"acquired":false,"shares":1642,"price":18.37,"value":30163.54,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units assumed pursuant to the Agreement and Plan of Merger, dated as of November 7, 2022 by and among Fulgent Genetics, Inc., FG Merger Sub, Inc., Fulgent Pharma Holdings, Inc., and the stockholders listed therein. These awards were originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on November 9, 2022."}],"balance_after":959639,"source":{"system":"sec-edgar","filing":"0000950170-25-099791","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1684532/000095017025099791/ownership.xml","form_type":"4"}},{"id":1125014,"issuer":{"id":2545,"kind":"organization","name":"Fulgent Genetics, Inc.","symbol":"FLGT"},"owners":[{"id":2548,"kind":"person","name":"Gao Hanlin","position":1,"cik":"0001684532","reported_name":"Gao Hanlin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2025-06-03T20:47:01.000Z","date":"2025-06-02","kind":"sale","planned":false,"acquired":false,"shares":754,"price":20.2908,"value":15299.2632,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were sold from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units granted to the reporting person on February 28, 2022, which grants were originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on March 2, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The shares were sold in multiple transactions at prices ranging from $20.01 to $20.70, inclusive. The reported price reflects the weighted-average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected."}],"balance_after":961281,"source":{"system":"sec-edgar","filing":"0000950170-25-081048","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1684532/000095017025081048/ownership.xml","form_type":"4"}},{"id":1131885,"issuer":{"id":2545,"kind":"organization","name":"Fulgent Genetics, Inc.","symbol":"FLGT"},"owners":[{"id":2548,"kind":"person","name":"Gao Hanlin","position":1,"cik":"0001684532","reported_name":"Gao Hanlin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2025-05-28T20:16:19.000Z","date":"2025-05-27","kind":"sale","planned":false,"acquired":false,"shares":656,"price":20.5169,"value":13459.0864,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"The shares were sold from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units granted to the reporting person on February 26, 2024, which grants were originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on February 28, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The shares were sold in multiple transactions at prices ranging from $20.445 to $20.56, inclusive. The reported price reflects the weighted-average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected."}],"balance_after":962035,"source":{"system":"sec-edgar","filing":"0000950170-25-078346","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1684532/000095017025078346/ownership.xml","form_type":"4"}},{"id":1131884,"issuer":{"id":2545,"kind":"organization","name":"Fulgent Genetics, Inc.","symbol":"FLGT"},"owners":[{"id":2548,"kind":"person","name":"Gao Hanlin","position":1,"cik":"0001684532","reported_name":"Gao Hanlin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2025-05-28T20:16:19.000Z","date":"2025-05-27","kind":"sale","planned":false,"acquired":false,"shares":383,"price":20.5753,"value":7880.3399,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were sold from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units granted to the reporting person on February 23, 2023, which grants were originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on February 27, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The shares were sold in multiple transactions at prices ranging from $20.41 to $20.79, inclusive. The reported price reflects the weighted-average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected."}],"balance_after":962691,"source":{"system":"sec-edgar","filing":"0000950170-25-078346","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1684532/000095017025078346/ownership.xml","form_type":"4"}},{"id":1161184,"issuer":{"id":2545,"kind":"organization","name":"Fulgent Genetics, Inc.","symbol":"FLGT"},"owners":[{"id":2548,"kind":"person","name":"Gao Hanlin","position":1,"cik":"0001684532","reported_name":"Gao Hanlin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2025-05-02T20:53:04.000Z","date":"2025-04-30","kind":"tax_withholding","planned":false,"acquired":false,"shares":79,"price":17.35,"value":1370.65,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units granted to the reporting person on April 30, 2021, which grant was originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on May 3, 2021."}],"balance_after":963074,"source":{"system":"sec-edgar","filing":"0000950170-25-062886","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1684532/000095017025062886/ownership.xml","form_type":"4"}},{"id":1163900,"issuer":{"id":2545,"kind":"organization","name":"Fulgent Genetics, Inc.","symbol":"FLGT"},"owners":[{"id":2548,"kind":"person","name":"Gao Hanlin","position":1,"cik":"0001684532","reported_name":"Gao Hanlin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2025-04-29T20:54:17.000Z","date":"2025-04-26","kind":"tax_withholding","planned":false,"acquired":false,"shares":1157,"price":18.88,"value":21844.16,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units assumed pursuant to the Agreement and Plan of Merger, dated as of November 7, 2022 by and among Fulgent Genetics, Inc., FG Merger Sub, Inc., Fulgent Pharma Holdings, Inc., and the stockholders listed therein. These awards were originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on November 9, 2022."}],"balance_after":963153,"source":{"system":"sec-edgar","filing":"0000950170-25-060278","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1684532/000095017025060278/ownership.xml","form_type":"4"}},{"id":1228536,"issuer":{"id":2545,"kind":"organization","name":"Fulgent Genetics, Inc.","symbol":"FLGT"},"owners":[{"id":2548,"kind":"person","name":"Gao Hanlin","position":1,"cik":"0001684532","reported_name":"Gao Hanlin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2025-03-05T01:06:14.000Z","date":"2025-03-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":985,"price":15.45,"value":15218.25,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units granted to the reporting person on February 28, 2022, which grants were originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on March 2, 2022."}],"balance_after":964310,"source":{"system":"sec-edgar","filing":"0000950170-25-032772","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1684532/000095017025032772/ownership.xml","form_type":"4"}},{"id":1240750,"issuer":{"id":2545,"kind":"organization","name":"Fulgent Genetics, Inc.","symbol":"FLGT"},"owners":[{"id":2548,"kind":"person","name":"Gao Hanlin","position":1,"cik":"0001684532","reported_name":"Gao Hanlin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2025-02-28T02:04:39.000Z","date":"2025-02-26","kind":"tax_withholding","planned":false,"acquired":false,"shares":2523,"price":16.24,"value":40973.52,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F8","text":"The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units granted to the reporting person on February 26, 2024, which grant was originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on February 28, 2024."}],"balance_after":965295,"source":{"system":"sec-edgar","filing":"0000950170-25-029435","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1684532/000095017025029435/ownership.xml","form_type":"4"}},{"id":1240749,"issuer":{"id":2545,"kind":"organization","name":"Fulgent Genetics, Inc.","symbol":"FLGT"},"owners":[{"id":2548,"kind":"person","name":"Gao Hanlin","position":1,"cik":"0001684532","reported_name":"Gao Hanlin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2025-02-28T02:04:39.000Z","date":"2025-02-25","kind":"grant","planned":false,"acquired":true,"shares":37790,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F7","text":"Restricted stock units. The shares subject to the restricted stock units vest over a period of three years, with 1/3rd of such shares vesting 12 months after March 1, 2025, and 1/12th of such shares vesting at the end of every three-month period thereafter over the remaining 24 months, subject to continued service for Issuer on each vesting date."}],"balance_after":967818,"source":{"system":"sec-edgar","filing":"0000950170-25-029435","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1684532/000095017025029435/ownership.xml","form_type":"4"}},{"id":1240748,"issuer":{"id":2545,"kind":"organization","name":"Fulgent Genetics, Inc.","symbol":"FLGT"},"owners":[{"id":2548,"kind":"person","name":"Gao Hanlin","position":1,"cik":"0001684532","reported_name":"Gao Hanlin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2025-02-28T02:04:39.000Z","date":"2025-02-25","kind":"tax_withholding","planned":false,"acquired":false,"shares":4639,"price":16.29,"value":75569.31,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F6","text":"The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of the above performance-based restricted stock units granted to the reporting person on February 26, 2024."}],"balance_after":930028,"source":{"system":"sec-edgar","filing":"0000950170-25-029435","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1684532/000095017025029435/ownership.xml","form_type":"4"}},{"id":1240747,"issuer":{"id":2545,"kind":"organization","name":"Fulgent Genetics, Inc.","symbol":"FLGT"},"owners":[{"id":2548,"kind":"person","name":"Gao Hanlin","position":1,"cik":"0001684532","reported_name":"Gao Hanlin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2025-02-28T02:04:39.000Z","date":"2025-02-25","kind":"tax_withholding","planned":false,"acquired":false,"shares":1636,"price":16.29,"value":26650.44,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F5","text":"The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of the above performance-based restricted stock units granted to the reporting person on February 23, 2023."}],"balance_after":934667,"source":{"system":"sec-edgar","filing":"0000950170-25-029435","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1684532/000095017025029435/ownership.xml","form_type":"4"}},{"id":1240746,"issuer":{"id":2545,"kind":"organization","name":"Fulgent Genetics, Inc.","symbol":"FLGT"},"owners":[{"id":2548,"kind":"person","name":"Gao Hanlin","position":1,"cik":"0001684532","reported_name":"Gao Hanlin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2025-02-28T02:04:39.000Z","date":"2025-02-25","kind":"tax_withholding","planned":false,"acquired":false,"shares":1211,"price":16.29,"value":19727.19,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of the above performance-based restricted stock units granted to the reporting person on February 28, 2022."}],"balance_after":936303,"source":{"system":"sec-edgar","filing":"0000950170-25-029435","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1684532/000095017025029435/ownership.xml","form_type":"4"}},{"id":1240745,"issuer":{"id":2545,"kind":"organization","name":"Fulgent Genetics, Inc.","symbol":"FLGT"},"owners":[{"id":2548,"kind":"person","name":"Gao Hanlin","position":1,"cik":"0001684532","reported_name":"Gao Hanlin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2025-02-28T02:04:39.000Z","date":"2025-02-25","kind":"grant","planned":false,"acquired":true,"shares":11926,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Performance-based restricted stock units. The shares vested pursuant to certain performance milestones for performance-based restricted stock units granted on February 26, 2024."}],"balance_after":937514,"source":{"system":"sec-edgar","filing":"0000950170-25-029435","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1684532/000095017025029435/ownership.xml","form_type":"4"}},{"id":1240744,"issuer":{"id":2545,"kind":"organization","name":"Fulgent Genetics, Inc.","symbol":"FLGT"},"owners":[{"id":2548,"kind":"person","name":"Gao Hanlin","position":1,"cik":"0001684532","reported_name":"Gao Hanlin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2025-02-28T02:04:39.000Z","date":"2025-02-25","kind":"grant","planned":false,"acquired":true,"shares":4571,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Performance-based restricted stock units. The shares vested pursuant to certain performance milestones for performance-based restricted stock units granted on February 23, 2023."}],"balance_after":925588,"source":{"system":"sec-edgar","filing":"0000950170-25-029435","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1684532/000095017025029435/ownership.xml","form_type":"4"}},{"id":1240743,"issuer":{"id":2545,"kind":"organization","name":"Fulgent Genetics, Inc.","symbol":"FLGT"},"owners":[{"id":2548,"kind":"person","name":"Gao Hanlin","position":1,"cik":"0001684532","reported_name":"Gao Hanlin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2025-02-28T02:04:39.000Z","date":"2025-02-25","kind":"grant","planned":false,"acquired":true,"shares":3384,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Performance-based restricted stock units. The shares vested pursuant to certain performance milestones for performance-based restricted stock units granted on February 28, 2022."}],"balance_after":921017,"source":{"system":"sec-edgar","filing":"0000950170-25-029435","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1684532/000095017025029435/ownership.xml","form_type":"4"}},{"id":1246233,"issuer":{"id":2545,"kind":"organization","name":"Fulgent Genetics, Inc.","symbol":"FLGT"},"owners":[{"id":2548,"kind":"person","name":"Gao Hanlin","position":1,"cik":"0001684532","reported_name":"Gao Hanlin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2025-02-25T22:25:59.000Z","date":"2025-02-23","kind":"tax_withholding","planned":false,"acquired":false,"shares":417,"price":16.46,"value":6863.82,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units granted to the reporting person on February 23, 2023, which grant was originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on February 27, 2023."}],"balance_after":917633,"source":{"system":"sec-edgar","filing":"0000950170-25-026884","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1684532/000095017025026884/ownership.xml","form_type":"4"}},{"id":1287416,"issuer":{"id":2545,"kind":"organization","name":"Fulgent Genetics, Inc.","symbol":"FLGT"},"owners":[{"id":2548,"kind":"person","name":"Gao Hanlin","position":1,"cik":"0001684532","reported_name":"Gao Hanlin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2025-02-03T22:05:54.000Z","date":"2025-01-30","kind":"tax_withholding","planned":false,"acquired":false,"shares":90,"price":17,"value":1530.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units granted to the reporting person on April 30, 2021, which grant was originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on May 3, 2021."}],"balance_after":918050,"source":{"system":"sec-edgar","filing":"0000950170-25-012439","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1684532/000095017025012439/ownership.xml","form_type":"4"}},{"id":1293079,"issuer":{"id":2545,"kind":"organization","name":"Fulgent Genetics, Inc.","symbol":"FLGT"},"owners":[{"id":2548,"kind":"person","name":"Gao Hanlin","position":1,"cik":"0001684532","reported_name":"Gao Hanlin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2025-01-28T21:28:34.000Z","date":"2025-01-26","kind":"tax_withholding","planned":false,"acquired":false,"shares":1329,"price":17.21,"value":22872.09,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units assumed pursuant to the Agreement and Plan of Merger, dated as of November 7, 2022 by and among Fulgent Genetics, Inc., FG Merger Sub, Inc., Fulgent Pharma Holdings, Inc., and the stockholders listed therein. These awards were originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on November 9, 2022."}],"balance_after":918140,"source":{"system":"sec-edgar","filing":"0000950170-25-009841","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1684532/000095017025009841/ownership.xml","form_type":"4"}},{"id":1342959,"issuer":{"id":2545,"kind":"organization","name":"Fulgent Genetics, Inc.","symbol":"FLGT"},"owners":[{"id":2548,"kind":"person","name":"Gao Hanlin","position":1,"cik":"0001684532","reported_name":"Gao Hanlin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2024-12-04T21:40:24.000Z","date":"2024-12-03","kind":"sale","planned":false,"acquired":false,"shares":1373,"price":19.4999,"value":26773.3627,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were sold from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units granted to the reporting person on February 28, 2022, which grants were originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on March 2, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The shares were sold in multiple transactions at prices ranging from $19.46 to $19.58, inclusive. The reported price reflects the weighted-average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected."}],"balance_after":919469,"source":{"system":"sec-edgar","filing":"0000950170-24-133308","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1684532/000095017024133308/ownership.xml","form_type":"4"}},{"id":1349409,"issuer":{"id":2545,"kind":"organization","name":"Fulgent Genetics, Inc.","symbol":"FLGT"},"owners":[{"id":2548,"kind":"person","name":"Gao Hanlin","position":1,"cik":"0001684532","reported_name":"Gao Hanlin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2024-11-27T22:00:06.000Z","date":"2024-11-25","kind":"sale","planned":false,"acquired":false,"shares":497,"price":18.2593,"value":9074.8721,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were sold by the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units granted to the reporting person on February 23, 2023, which grant was originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on February 27, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The shares were sold in multiple transactions at prices ranging from $18.12 to $18.50, inclusive. The reported price reflects the weighted-average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected."}],"balance_after":920842,"source":{"system":"sec-edgar","filing":"0000950170-24-131595","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1684532/000095017024131595/ownership.xml","form_type":"4"}},{"id":1378204,"issuer":{"id":2545,"kind":"organization","name":"Fulgent Genetics, Inc.","symbol":"FLGT"},"owners":[{"id":2548,"kind":"person","name":"Gao Hanlin","position":1,"cik":"0001684532","reported_name":"Gao Hanlin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2024-11-01T20:30:04.000Z","date":"2024-10-30","kind":"tax_withholding","planned":false,"acquired":false,"shares":79,"price":20.27,"value":1601.33,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units granted to the reporting person on April 30, 2021, which grant was originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on May 3, 2021."}],"balance_after":921339,"source":{"system":"sec-edgar","filing":"0000950170-24-120110","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1684532/000095017024120110/ownership.xml","form_type":"4"}},{"id":1380043,"issuer":{"id":2545,"kind":"organization","name":"Fulgent Genetics, Inc.","symbol":"FLGT"},"owners":[{"id":2548,"kind":"person","name":"Gao Hanlin","position":1,"cik":"0001684532","reported_name":"Gao Hanlin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2024-10-29T20:30:15.000Z","date":"2024-10-26","kind":"tax_withholding","planned":false,"acquired":false,"shares":1639,"price":19.42,"value":31829.38,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units granted to the reporting person on November 7, 2022, which grant was originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on November 9, 2022."}],"balance_after":921418,"source":{"system":"sec-edgar","filing":"0000950170-24-118288","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1684532/000095017024118288/ownership.xml","form_type":"4"}},{"id":1413959,"issuer":{"id":2545,"kind":"organization","name":"Fulgent Genetics, Inc.","symbol":"FLGT"},"owners":[{"id":2548,"kind":"person","name":"Gao Hanlin","position":1,"cik":"0001684532","reported_name":"Gao Hanlin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2024-09-05T20:20:53.000Z","date":"2024-09-03","kind":"sale","planned":false,"acquired":false,"shares":1503,"price":21.961,"value":33007.383,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were sold from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units granted to the reporting person on February 28, 2022, which grants were originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on March 2, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The shares were sold in multiple transactions at prices ranging from $21.815 to $22.10, inclusive. The reported price reflects the weighted-average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected."}],"balance_after":923057,"source":{"system":"sec-edgar","filing":"0000950170-24-104016","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1684532/000095017024104016/ownership.xml","form_type":"4"}},{"id":1419937,"issuer":{"id":2545,"kind":"organization","name":"Fulgent Genetics, Inc.","symbol":"FLGT"},"owners":[{"id":2548,"kind":"person","name":"Gao Hanlin","position":1,"cik":"0001684532","reported_name":"Gao Hanlin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2024-08-29T22:34:13.000Z","date":"2024-08-27","kind":"sale","planned":false,"acquired":false,"shares":563,"price":22.833,"value":12854.979,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were sold by the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units granted to the reporting person on February 23, 2023, which grant was originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on February 27, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The shares were sold in multiple transactions at prices ranging from $22.72 to $22.915, inclusive. The reported price reflects the weighted-average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected."}],"balance_after":924560,"source":{"system":"sec-edgar","filing":"0000950170-24-101991","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1684532/000095017024101991/ownership.xml","form_type":"4"}},{"id":1444325,"issuer":{"id":2545,"kind":"organization","name":"Fulgent Genetics, Inc.","symbol":"FLGT"},"owners":[{"id":2548,"kind":"person","name":"Gao Hanlin","position":1,"cik":"0001684532","reported_name":"Gao Hanlin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2024-08-01T20:03:18.000Z","date":"2024-07-30","kind":"tax_withholding","planned":false,"acquired":false,"shares":111,"price":23.95,"value":2658.45,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units granted to the reporting person on April 30, 2021, which grant was originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on May 3, 2021."}],"balance_after":925123,"source":{"system":"sec-edgar","filing":"0000950170-24-089239","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1684532/000095017024089239/ownership.xml","form_type":"4"}},{"id":1446264,"issuer":{"id":2545,"kind":"organization","name":"Fulgent Genetics, Inc.","symbol":"FLGT"},"owners":[{"id":2548,"kind":"person","name":"Gao Hanlin","position":1,"cik":"0001684532","reported_name":"Gao Hanlin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2024-07-30T20:27:49.000Z","date":"2024-07-26","kind":"tax_withholding","planned":false,"acquired":false,"shares":1154,"price":23.66,"value":27303.64,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units granted to the reporting person on November 7, 2022, which grant was originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on November 9, 2022."}],"balance_after":925234,"source":{"system":"sec-edgar","filing":"0000950170-24-087889","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1684532/000095017024087889/ownership.xml","form_type":"4"}},{"id":1492326,"issuer":{"id":2545,"kind":"organization","name":"Fulgent Genetics, Inc.","symbol":"FLGT"},"owners":[{"id":2548,"kind":"person","name":"Gao Hanlin","position":1,"cik":"0001684532","reported_name":"Gao Hanlin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2024-06-04T20:56:26.000Z","date":"2024-06-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":268,"price":20.65,"value":5534.2,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units granted to the reporting person on February 28, 2022, which grants were originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on March 2, 2022."}],"balance_after":926388,"source":{"system":"sec-edgar","filing":"0000950170-24-068791","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1684532/000095017024068791/ownership.xml","form_type":"4"}},{"id":1492325,"issuer":{"id":2545,"kind":"organization","name":"Fulgent Genetics, Inc.","symbol":"FLGT"},"owners":[{"id":2548,"kind":"person","name":"Gao Hanlin","position":1,"cik":"0001684532","reported_name":"Gao Hanlin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2024-06-04T20:56:26.000Z","date":"2024-06-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":714,"price":20.65,"value":14744.1,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units granted to the reporting person on February 28, 2022, which grants were originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on March 2, 2022."}],"balance_after":926656,"source":{"system":"sec-edgar","filing":"0000950170-24-068791","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1684532/000095017024068791/ownership.xml","form_type":"4"}},{"id":1500424,"issuer":{"id":2545,"kind":"organization","name":"Fulgent Genetics, Inc.","symbol":"FLGT"},"owners":[{"id":2548,"kind":"person","name":"Gao Hanlin","position":1,"cik":"0001684532","reported_name":"Gao Hanlin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2024-05-28T20:22:46.000Z","date":"2024-05-23","kind":"tax_withholding","planned":false,"acquired":false,"shares":362,"price":21.14,"value":7652.68,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units granted to the reporting person on February 23, 2023, which grant was originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on February 27, 2023."}],"balance_after":927370,"source":{"system":"sec-edgar","filing":"0000950170-24-065236","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1684532/000095017024065236/ownership.xml","form_type":"4"}},{"id":1530591,"issuer":{"id":2545,"kind":"organization","name":"Fulgent Genetics, Inc.","symbol":"FLGT"},"owners":[{"id":2548,"kind":"person","name":"Gao Hanlin","position":1,"cik":"0001684532","reported_name":"Gao Hanlin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2024-05-02T20:35:14.000Z","date":"2024-04-30","kind":"tax_withholding","planned":false,"acquired":false,"shares":79,"price":20.35,"value":1607.65,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units granted to the reporting person on April 30, 2021, which grant was originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on May 3, 2021."}],"balance_after":927732,"source":{"system":"sec-edgar","filing":"0000950170-24-052222","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1684532/000095017024052222/ownership.xml","form_type":"4"}},{"id":1532873,"issuer":{"id":2545,"kind":"organization","name":"Fulgent Genetics, Inc.","symbol":"FLGT"},"owners":[{"id":2548,"kind":"person","name":"Gao Hanlin","position":1,"cik":"0001684532","reported_name":"Gao Hanlin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2024-04-30T20:02:48.000Z","date":"2024-04-26","kind":"tax_withholding","planned":false,"acquired":false,"shares":1154,"price":20.1,"value":23195.4,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units granted to the reporting person on November 7, 2022, which grant was originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on November 9, 2022."}],"balance_after":927811,"source":{"system":"sec-edgar","filing":"0000950170-24-050506","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1684532/000095017024050506/ownership.xml","form_type":"4"}},{"id":1596345,"issuer":{"id":2545,"kind":"organization","name":"Fulgent Genetics, Inc.","symbol":"FLGT"},"owners":[{"id":2548,"kind":"person","name":"Gao Hanlin","position":1,"cik":"0001684532","reported_name":"Gao Hanlin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2024-03-05T21:26:49.000Z","date":"2024-03-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":268,"price":23.24,"value":6228.32,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units granted to the reporting person on February 28, 2022, which grant was originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on March 2, 2022."}],"balance_after":928965,"source":{"system":"sec-edgar","filing":"0000950170-24-026004","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1684532/000095017024026004/ownership.xml","form_type":"4"}},{"id":1596344,"issuer":{"id":2545,"kind":"organization","name":"Fulgent Genetics, Inc.","symbol":"FLGT"},"owners":[{"id":2548,"kind":"person","name":"Gao Hanlin","position":1,"cik":"0001684532","reported_name":"Gao Hanlin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2024-03-05T21:26:49.000Z","date":"2024-03-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":704,"price":23.24,"value":16360.96,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units granted to the reporting person on February 28, 2022, which grant was originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on March 2, 2022."}],"balance_after":929233,"source":{"system":"sec-edgar","filing":"0000950170-24-026004","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1684532/000095017024026004/ownership.xml","form_type":"4"}},{"id":1612358,"issuer":{"id":2545,"kind":"organization","name":"Fulgent Genetics, Inc.","symbol":"FLGT"},"owners":[{"id":2548,"kind":"person","name":"Gao Hanlin","position":1,"cik":"0001684532","reported_name":"Gao Hanlin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2024-02-29T00:12:13.000Z","date":"2024-02-26","kind":"grant","planned":false,"acquired":true,"shares":21146,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F5","text":"Restricted stock units. The shares subject to the restricted stock units vest over a period of three years, with 1/3rd of such shares vesting 12 months after February 26, 2024, and 1/12th of such shares vesting at the end of every three month period thereafter over the remaining 24 months, subject to continued service for Issuer on each vesting date."}],"balance_after":929937,"source":{"system":"sec-edgar","filing":"0000950170-24-022468","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1684532/000095017024022468/ownership.xml","form_type":"4"}},{"id":1612357,"issuer":{"id":2545,"kind":"organization","name":"Fulgent Genetics, Inc.","symbol":"FLGT"},"owners":[{"id":2548,"kind":"person","name":"Gao Hanlin","position":1,"cik":"0001684532","reported_name":"Gao Hanlin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2024-02-29T00:12:13.000Z","date":"2024-02-26","kind":"tax_withholding","planned":false,"acquired":false,"shares":1888,"price":24.26,"value":45802.88,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of the above performance-based restricted stock units granted to the reporting person on February 23, 2023."}],"balance_after":908791,"source":{"system":"sec-edgar","filing":"0000950170-24-022468","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1684532/000095017024022468/ownership.xml","form_type":"4"}},{"id":1612356,"issuer":{"id":2545,"kind":"organization","name":"Fulgent Genetics, Inc.","symbol":"FLGT"},"owners":[{"id":2548,"kind":"person","name":"Gao Hanlin","position":1,"cik":"0001684532","reported_name":"Gao Hanlin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2024-02-29T00:12:13.000Z","date":"2024-02-26","kind":"tax_withholding","planned":false,"acquired":false,"shares":1402,"price":24.26,"value":34012.52,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of the above performance-based restricted stock units granted to the reporting person on February 28, 2022."}],"balance_after":910679,"source":{"system":"sec-edgar","filing":"0000950170-24-022468","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1684532/000095017024022468/ownership.xml","form_type":"4"}},{"id":1612355,"issuer":{"id":2545,"kind":"organization","name":"Fulgent Genetics, Inc.","symbol":"FLGT"},"owners":[{"id":2548,"kind":"person","name":"Gao Hanlin","position":1,"cik":"0001684532","reported_name":"Gao Hanlin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2024-02-29T00:12:13.000Z","date":"2024-02-26","kind":"grant","planned":false,"acquired":true,"shares":5304,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Performance-based restricted stock units. The shares vested pursuant to certain performance milestones for performance-based restricted stock units granted on February 23, 2023."}],"balance_after":912081,"source":{"system":"sec-edgar","filing":"0000950170-24-022468","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1684532/000095017024022468/ownership.xml","form_type":"4"}},{"id":1612354,"issuer":{"id":2545,"kind":"organization","name":"Fulgent Genetics, Inc.","symbol":"FLGT"},"owners":[{"id":2548,"kind":"person","name":"Gao Hanlin","position":1,"cik":"0001684532","reported_name":"Gao Hanlin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2024-02-29T00:12:13.000Z","date":"2024-02-26","kind":"grant","planned":false,"acquired":true,"shares":3927,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Performance-based restricted stock units. The shares vested pursuant to certain performance milestones for performance-based restricted stock units granted on February 28, 2022."}],"balance_after":906777,"source":{"system":"sec-edgar","filing":"0000950170-24-022468","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1684532/000095017024022468/ownership.xml","form_type":"4"}},{"id":1615893,"issuer":{"id":2545,"kind":"organization","name":"Fulgent Genetics, Inc.","symbol":"FLGT"},"owners":[{"id":2548,"kind":"person","name":"Gao Hanlin","position":1,"cik":"0001684532","reported_name":"Gao Hanlin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2024-02-27T23:50:35.000Z","date":"2024-02-23","kind":"tax_withholding","planned":false,"acquired":false,"shares":1617,"price":24.06,"value":38905.02,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units granted to the reporting person on February 23, 2023, which grant was originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on February 27, 2023."}],"balance_after":902850,"source":{"system":"sec-edgar","filing":"0000950170-24-021517","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1684532/000095017024021517/ownership.xml","form_type":"4"}},{"id":1663931,"issuer":{"id":2545,"kind":"organization","name":"Fulgent Genetics, Inc.","symbol":"FLGT"},"owners":[{"id":2548,"kind":"person","name":"Gao Hanlin","position":1,"cik":"0001684532","reported_name":"Gao Hanlin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2024-02-01T21:39:26.000Z","date":"2024-01-30","kind":"tax_withholding","planned":false,"acquired":false,"shares":90,"price":25,"value":2250.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units granted to the reporting person on April 30, 2021, which grant was originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on May 3, 2021."}],"balance_after":904467,"source":{"system":"sec-edgar","filing":"0000950170-24-009853","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1684532/000095017024009853/ownership.xml","form_type":"4"}},{"id":1666519,"issuer":{"id":2545,"kind":"organization","name":"Fulgent Genetics, Inc.","symbol":"FLGT"},"owners":[{"id":2548,"kind":"person","name":"Gao Hanlin","position":1,"cik":"0001684532","reported_name":"Gao Hanlin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2024-01-30T21:21:31.000Z","date":"2024-01-26","kind":"tax_withholding","planned":false,"acquired":false,"shares":1325,"price":25.6,"value":33920.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units granted to the reporting person on November 7, 2022, which grant was originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on November, 9 2022."}],"balance_after":904557,"source":{"system":"sec-edgar","filing":"0000950170-24-008854","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1684532/000095017024008854/ownership.xml","form_type":"4"}},{"id":1720108,"issuer":{"id":2545,"kind":"organization","name":"Fulgent Genetics, Inc.","symbol":"FLGT"},"owners":[{"id":2548,"kind":"person","name":"Gao Hanlin","position":1,"cik":"0001684532","reported_name":"Gao Hanlin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2023-12-06T22:47:43.000Z","date":"2023-12-04","kind":"sale","planned":false,"acquired":false,"shares":1437,"price":27.5732,"value":39622.6884,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were sold by the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units granted to the reporting person on February 28, 2022, which grant was originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on March 2, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The shares were sold in multiple transactions at prices ranging from $27.25 to $27.79, inclusive. The reported price reflects the weighted-average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected."}],"balance_after":905882,"source":{"system":"sec-edgar","filing":"0001209191-23-057662","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1684532/000120919123057662/doc4.xml","form_type":"4"}},{"id":1752467,"issuer":{"id":2545,"kind":"organization","name":"Fulgent Genetics, Inc.","symbol":"FLGT"},"owners":[{"id":2548,"kind":"person","name":"Gao Hanlin","position":1,"cik":"0001684532","reported_name":"Gao Hanlin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2023-11-01T21:38:05.000Z","date":"2023-10-30","kind":"tax_withholding","planned":false,"acquired":false,"shares":109,"price":23.64,"value":2576.76,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units granted to the reporting person on April 30, 2021, which grants were originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on May 3, 2021."}],"balance_after":907319,"source":{"system":"sec-edgar","filing":"0001209191-23-054046","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1684532/000120919123054046/doc4.xml","form_type":"4"}},{"id":1753831,"issuer":{"id":2545,"kind":"organization","name":"Fulgent Genetics, Inc.","symbol":"FLGT"},"owners":[{"id":2548,"kind":"person","name":"Gao Hanlin","position":1,"cik":"0001684532","reported_name":"Gao Hanlin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2023-10-30T21:24:07.000Z","date":"2023-10-26","kind":"tax_withholding","planned":false,"acquired":false,"shares":5504,"price":24.025,"value":132233.6,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units held by the reporting person and assumed by the Issuer on November 7, 2022, which grant was originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on November 9, 2022."}],"balance_after":907428,"source":{"system":"sec-edgar","filing":"0001209191-23-053870","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1684532/000120919123053870/doc4.xml","form_type":"4"}},{"id":1783912,"issuer":{"id":2545,"kind":"organization","name":"Fulgent Genetics, Inc.","symbol":"FLGT"},"owners":[{"id":2548,"kind":"person","name":"Gao Hanlin","position":1,"cik":"0001684532","reported_name":"Gao Hanlin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2023-09-11T20:34:01.000Z","date":"2023-09-07","kind":"sale","planned":false,"acquired":false,"shares":1041,"price":31.4079,"value":32695.6239,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were sold from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units granted to the reporting person on February 28, 2022, which grants were originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on March 2, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The shares were sold in multiple transactions at prices ranging from $31.345 to $31.56, inclusive. The reported price reflects the weighted-average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected."}],"balance_after":912932,"source":{"system":"sec-edgar","filing":"0001209191-23-048930","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1684532/000120919123048930/doc4.xml","form_type":"4"}},{"id":1800785,"issuer":{"id":2545,"kind":"organization","name":"Fulgent Genetics, Inc.","symbol":"FLGT"},"owners":[{"id":2548,"kind":"person","name":"Gao Hanlin","position":1,"cik":"0001684532","reported_name":"Gao Hanlin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2023-08-21T20:34:02.000Z","date":"2023-08-17","kind":"sale","planned":false,"acquired":false,"shares":342,"price":33.8811,"value":11587.3362,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were sold by the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units granted to the reporting person on August 1, 2019, which grant was originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on August 5, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The shares were sold in multiple transactions at prices ranging from $33.55 to $34.19, inclusive. The reported price reflects the weighted-average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected."}],"balance_after":913973,"source":{"system":"sec-edgar","filing":"0001209191-23-046712","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1684532/000120919123046712/doc4.xml","form_type":"4"}},{"id":1819212,"issuer":{"id":2545,"kind":"organization","name":"Fulgent Genetics, Inc.","symbol":"FLGT"},"owners":[{"id":2548,"kind":"person","name":"Gao Hanlin","position":1,"cik":"0001684532","reported_name":"Gao Hanlin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2023-08-01T21:14:51.000Z","date":"2023-07-30","kind":"tax_withholding","planned":false,"acquired":false,"shares":76,"price":38.63,"value":2935.88,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units granted to the reporting person on April 30, 2021, which grants were originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on May 3, 2021."}],"balance_after":914315,"source":{"system":"sec-edgar","filing":"0001209191-23-044023","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1684532/000120919123044023/doc4.xml","form_type":"4"}},{"id":1865208,"issuer":{"id":2545,"kind":"organization","name":"Fulgent Genetics, Inc.","symbol":"FLGT"},"owners":[{"id":2548,"kind":"person","name":"Gao Hanlin","position":1,"cik":"0001684532","reported_name":"Gao Hanlin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2023-06-06T21:06:22.000Z","date":"2023-06-02","kind":"sale","planned":false,"acquired":false,"shares":1000,"price":40.2961,"value":40296.1,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were sold from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units granted to the reporting person on February 28, 2022, which grants were originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on March 2, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The shares were sold in multiple transactions at prices ranging from $39.79 to $40.75, inclusive. The reported price reflects the weighted-average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected."}],"balance_after":914391,"source":{"system":"sec-edgar","filing":"0001209191-23-034790","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1684532/000120919123034790/doc4.xml","form_type":"4"}},{"id":1884660,"issuer":{"id":2545,"kind":"organization","name":"Fulgent Genetics, Inc.","symbol":"FLGT"},"owners":[{"id":2548,"kind":"person","name":"Gao Hanlin","position":1,"cik":"0001684532","reported_name":"Gao Hanlin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2023-05-19T20:15:44.000Z","date":"2023-05-17","kind":"sale","planned":false,"acquired":false,"shares":345,"price":35.4623,"value":12234.4935,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were sold by the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units granted to the reporting person on August 1, 2019, which grant was originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on August 5, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The shares were sold in multiple transactions at prices ranging from $34.96 to $36.15, inclusive. The reported price reflects the weighted-average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected."}],"balance_after":915391,"source":{"system":"sec-edgar","filing":"0001209191-23-030994","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1684532/000120919123030994/doc4.xml","form_type":"4"}},{"id":1908358,"issuer":{"id":2545,"kind":"organization","name":"Fulgent Genetics, Inc.","symbol":"FLGT"},"owners":[{"id":2548,"kind":"person","name":"Gao Hanlin","position":1,"cik":"0001684532","reported_name":"Gao Hanlin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2023-05-02T20:59:52.000Z","date":"2023-04-30","kind":"tax_withholding","planned":false,"acquired":false,"shares":76,"price":29.57,"value":2247.32,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units granted to the reporting person on April 30, 2021, which grants were originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on May 3, 2021."}],"balance_after":915736,"source":{"system":"sec-edgar","filing":"0001209191-23-026560","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1684532/000120919123026560/doc4.xml","form_type":"4"}},{"id":1973671,"issuer":{"id":2545,"kind":"organization","name":"Fulgent Genetics, Inc.","symbol":"FLGT"},"owners":[{"id":2548,"kind":"person","name":"Gao Hanlin","position":1,"cik":"0001684532","reported_name":"Gao Hanlin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2023-03-03T21:30:12.000Z","date":"2023-03-01","kind":"tax_withholding","acquired":false,"shares":3804,"price":31.85,"value":121157.4,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units granted to the reporting person on February 28, 2022, which grants were originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on March 2, 2022."}],"balance_after":915812,"source":{"system":"sec-edgar","filing":"0001209191-23-015514","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1684532/000120919123015514/doc4.xml","form_type":"4"}},{"id":1990411,"issuer":{"id":2545,"kind":"organization","name":"Fulgent Genetics, Inc.","symbol":"FLGT"},"owners":[{"id":2548,"kind":"person","name":"Gao Hanlin","position":1,"cik":"0001684532","reported_name":"Gao Hanlin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2023-02-27T22:16:16.000Z","date":"2023-02-23","kind":"tax_withholding","acquired":false,"shares":794,"price":31.65,"value":25130.1,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of the above performance-based restricted stock units granted to the reporting person on February 28, 2022."}],"balance_after":919616,"source":{"system":"sec-edgar","filing":"0001209191-23-013280","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1684532/000120919123013280/doc4.xml","form_type":"4"}},{"id":1990410,"issuer":{"id":2545,"kind":"organization","name":"Fulgent Genetics, Inc.","symbol":"FLGT"},"owners":[{"id":2548,"kind":"person","name":"Gao Hanlin","position":1,"cik":"0001684532","reported_name":"Gao Hanlin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2023-02-27T22:16:16.000Z","date":"2023-02-23","kind":"grant","acquired":true,"shares":12156,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Restricted stock units. The shares subject to the restricted stock units vest over a period of three years, with 1/3rd of such shares vesting 12 months after February 23, 2023, and 1/12th of such shares vesting at the end of every three-month period thereafter over the remaining 24 months, subject to continued service for Issuer on each vesting date."}],"balance_after":920410,"source":{"system":"sec-edgar","filing":"0001209191-23-013280","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1684532/000120919123013280/doc4.xml","form_type":"4"}},{"id":1990409,"issuer":{"id":2545,"kind":"organization","name":"Fulgent Genetics, Inc.","symbol":"FLGT"},"owners":[{"id":2548,"kind":"person","name":"Gao Hanlin","position":1,"cik":"0001684532","reported_name":"Gao Hanlin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2023-02-27T22:16:16.000Z","date":"2023-02-23","kind":"grant","acquired":true,"shares":2142,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Performance-based restricted stock units. The shares vested pursuant to certain performance milestones for performance-based restricted stock units granted on February 28, 2022."}],"balance_after":908254,"source":{"system":"sec-edgar","filing":"0001209191-23-013280","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1684532/000120919123013280/doc4.xml","form_type":"4"}},{"id":2007693,"issuer":{"id":2545,"kind":"organization","name":"Fulgent Genetics, Inc.","symbol":"FLGT"},"owners":[{"id":2548,"kind":"person","name":"Gao Hanlin","position":1,"cik":"0001684532","reported_name":"Gao Hanlin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2023-02-17T22:00:47.000Z","date":"2023-02-15","kind":"tax_withholding","acquired":false,"shares":383,"price":33.99,"value":13018.17,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units granted to the reporting person on August 1, 2019, which grant was originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on August 5, 2019."}],"balance_after":906112,"source":{"system":"sec-edgar","filing":"0001209191-23-010727","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1684532/000120919123010727/doc4.xml","form_type":"4"}},{"id":2038561,"issuer":{"id":2545,"kind":"organization","name":"Fulgent Genetics, Inc.","symbol":"FLGT"},"owners":[{"id":2548,"kind":"person","name":"Gao Hanlin","position":1,"cik":"0001684532","reported_name":"Gao Hanlin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2023-02-01T23:13:14.000Z","date":"2023-01-30","kind":"tax_withholding","acquired":false,"shares":90,"price":33.04,"value":2973.6,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units granted to the reporting person on April 30, 2021, which grant was originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on May 3, 2021."}],"balance_after":906495,"source":{"system":"sec-edgar","filing":"0001209191-23-005984","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1684532/000120919123005984/doc4.xml","form_type":"4"}},{"id":2110352,"issuer":{"id":2545,"kind":"organization","name":"Fulgent Genetics, Inc.","symbol":"FLGT"},"owners":[{"id":2548,"kind":"person","name":"Gao Hanlin","position":1,"cik":"0001684532","reported_name":"Gao Hanlin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2022-11-18T21:12:25.000Z","date":"2022-11-16","kind":"sale","acquired":false,"shares":342,"price":35.8906,"value":12274.5852,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were sold from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units granted to the reporting person on August 1, 2019, which grant was originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on August 5, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The shares were sold in multiple transactions at prices ranging from $35.515 to $36.370, inclusive. The reported price reflects the weighted-average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected."}],"balance_after":906585,"source":{"system":"sec-edgar","filing":"0001209191-22-057840","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1684532/000120919122057840/doc4.xml","form_type":"4"}},{"id":2121190,"issuer":{"id":2545,"kind":"organization","name":"Fulgent Genetics, Inc.","symbol":"FLGT"},"owners":[{"id":2548,"kind":"person","name":"Gao Hanlin","position":1,"cik":"0001684532","reported_name":"Gao Hanlin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2022-11-10T02:03:07.000Z","date":"2022-11-07","kind":"grant","acquired":true,"shares":51723,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to the Agreement and Plan of Merger, dated as of November 7, 2022 (the \"Merger Agreement\") by and among Fulgent Genetics, Inc. (\"Fulgent Genetics\"), FG Merger Sub, Inc. (\"FG\"), Fulgent Pharma Holdings, Inc. (\"Fulgent Pharma\"), and the stockholders listed therein, FG merged with and into Fulgent Pharma (the \"Merger\"), with Fulgent Pharma being the surviving corporation following the Merger. At the effective time of the Merger (the \"Effective Time\"), each award of restricted stock units (\"RSUs\") based on Fulgent Pharma common stock that was outstanding immediately prior to the Effective Time (\"Fulgent Pharma RSUs\") was assumed and converted into the right to receive RSUs based on the common stock of Fulgent Genetics with the same terms and conditions as the Fulgent Pharma RSUs immediately prior to the Effective Time, subject to the applicable exchange ratio."},{"field":"kind","element":"transactionCoding","label":"F2","text":"(continued from footnote 1) Twenty-five percent (25%) of the shares subject to RSUs reported herein will vest on the first anniversary of the date of the award, October 26, 2022, and 1/16th of the shares will vest every three months over the remaining 36-month period, subject to continued service for Issuer on each vesting date."}],"balance_after":906927,"source":{"system":"sec-edgar","filing":"0001209191-22-056316","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1684532/000120919122056316/doc4.xml","form_type":"4"}},{"id":2128479,"issuer":{"id":2545,"kind":"organization","name":"Fulgent Genetics, Inc.","symbol":"FLGT"},"owners":[{"id":2548,"kind":"person","name":"Gao Hanlin","position":1,"cik":"0001684532","reported_name":"Gao Hanlin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2022-11-01T21:06:40.000Z","date":"2022-10-30","kind":"tax_withholding","acquired":false,"shares":76,"price":40.28,"value":3061.28,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units granted to the reporting person on April 30, 2021, which grant was originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on May 3, 2021."}],"balance_after":855204,"source":{"system":"sec-edgar","filing":"0001209191-22-055074","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1684532/000120919122055074/doc4.xml","form_type":"4"}},{"id":2178273,"issuer":{"id":2545,"kind":"organization","name":"Fulgent Genetics, Inc.","symbol":"FLGT"},"owners":[{"id":2548,"kind":"person","name":"Gao Hanlin","position":1,"cik":"0001684532","reported_name":"Gao Hanlin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2022-08-19T21:04:39.000Z","date":"2022-08-17","kind":"sale","acquired":false,"shares":370,"price":48.8945,"value":18090.965,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were sold by the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units granted to the reporting person on August 1, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The shares were sold in multiple transactions at prices ranging from $48.67 to $49.02, inclusive. The reported price reflects the weighted-average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected."}],"balance_after":855280,"source":{"system":"sec-edgar","filing":"0001209191-22-046866","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1684532/000120919122046866/doc4.xml","form_type":"4"}},{"id":2197683,"issuer":{"id":2545,"kind":"organization","name":"Fulgent Genetics, Inc.","symbol":"FLGT"},"owners":[{"id":2548,"kind":"person","name":"Gao Hanlin","position":1,"cik":"0001684532","reported_name":"Gao Hanlin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2022-08-02T20:26:13.000Z","date":"2022-07-30","kind":"tax_withholding","acquired":false,"shares":87,"price":59.75,"value":5198.25,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units granted to the reporting person on April 30, 2021."}],"balance_after":855650,"source":{"system":"sec-edgar","filing":"0001209191-22-043871","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1684532/000120919122043871/doc4.xml","form_type":"4"}},{"id":2265717,"issuer":{"id":2545,"kind":"organization","name":"Fulgent Genetics, Inc.","symbol":"FLGT"},"owners":[{"id":2548,"kind":"person","name":"Gao Hanlin","position":1,"cik":"0001684532","reported_name":"Gao Hanlin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2022-05-18T20:37:40.000Z","date":"2022-05-16","kind":"sale","acquired":false,"shares":325,"price":53.3823,"value":17349.2475,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were sold by the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units granted to the reporting person on August 1, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The shares were sold in multiple transactions at prices ranging from $53.27 to $53.57, inclusive. The reported price reflects the weighted-average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected."}],"balance_after":855737,"source":{"system":"sec-edgar","filing":"0001209191-22-030061","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1684532/000120919122030061/doc4.xml","form_type":"4"}},{"id":2284339,"issuer":{"id":2545,"kind":"organization","name":"Fulgent Genetics, Inc.","symbol":"FLGT"},"owners":[{"id":2548,"kind":"person","name":"Gao Hanlin","position":1,"cik":"0001684532","reported_name":"Gao Hanlin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2022-05-03T21:15:38.000Z","date":"2022-04-30","kind":"tax_withholding","acquired":false,"shares":283,"price":54.88,"value":15531.04,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units granted to the reporting person on April 30, 2021."}],"balance_after":856062,"source":{"system":"sec-edgar","filing":"0001209191-22-026808","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1684532/000120919122026808/doc4.xml","form_type":"4"}},{"id":2360849,"issuer":{"id":2545,"kind":"organization","name":"Fulgent Genetics, Inc.","symbol":"FLGT"},"owners":[{"id":2548,"kind":"person","name":"Gao Hanlin","position":1,"cik":"0001684532","reported_name":"Gao Hanlin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2022-03-02T21:26:00.000Z","date":"2022-02-28","kind":"grant","acquired":true,"shares":32000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Restricted stock units. The shares subject to the restricted stock units vest over a period of four years, with 1/4th of such shares vesting 12 months after March 1, 2022, and 1/16th of such shares vesting at the end of every three-month period thereafter over the remaining 36 months, subject to continued service for Issuer on each vesting date."}],"balance_after":856345,"source":{"system":"sec-edgar","filing":"0001209191-22-014738","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1684532/000120919122014738/doc4.xml","form_type":"4"}},{"id":2360848,"issuer":{"id":2545,"kind":"organization","name":"Fulgent Genetics, Inc.","symbol":"FLGT"},"owners":[{"id":2548,"kind":"person","name":"Gao Hanlin","position":1,"cik":"0001684532","reported_name":"Gao Hanlin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2022-03-02T21:26:00.000Z","date":"2022-02-28","kind":"grant","acquired":true,"shares":9000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted stock units. The shares subject to the restricted stock units vest over a period of three years, with 1/3rd of such shares vesting 12 months after March 1, 2022, and 1/12th of such shares vesting at the end of every three-month period thereafter over the remaining 24 months, subject to continued service for Issuer on each vesting date."}],"balance_after":824345,"source":{"system":"sec-edgar","filing":"0001209191-22-014738","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1684532/000120919122014738/doc4.xml","form_type":"4"}},{"id":2388573,"issuer":{"id":2545,"kind":"organization","name":"Fulgent Genetics, Inc.","symbol":"FLGT"},"owners":[{"id":2548,"kind":"person","name":"Gao Hanlin","position":1,"cik":"0001684532","reported_name":"Gao Hanlin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2022-02-17T22:11:04.000Z","date":"2022-02-15","kind":"tax_withholding","acquired":false,"shares":303,"price":66.49,"value":20146.47,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units granted to the reporting person on August 1, 2019."}],"balance_after":815345,"source":{"system":"sec-edgar","filing":"0001209191-22-010875","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1684532/000120919122010875/doc4.xml","form_type":"4"}},{"id":2504877,"issuer":{"id":2545,"kind":"organization","name":"Fulgent Genetics, Inc.","symbol":"FLGT"},"owners":[{"id":2548,"kind":"person","name":"Gao Hanlin","position":1,"cik":"0001684532","reported_name":"Gao Hanlin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-11-18T21:58:49.000Z","date":"2021-11-16","kind":"sale","acquired":false,"shares":311,"price":95.5021,"value":29701.1531,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were sold by the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units granted to the reporting person on August 1, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The shares were sold in multiple transactions at prices ranging from $95.3400 to $95.6200, inclusive. The reported price reflects the weighted-average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected."}],"balance_after":815648,"source":{"system":"sec-edgar","filing":"0001209191-21-065504","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1684532/000120919121065504/doc4.xml","form_type":"4"}},{"id":2598109,"issuer":{"id":2545,"kind":"organization","name":"Fulgent Genetics, Inc.","symbol":"FLGT"},"owners":[{"id":2548,"kind":"person","name":"Gao Hanlin","position":1,"cik":"0001684532","reported_name":"Gao Hanlin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-08-18T21:54:11.000Z","date":"2021-08-16","kind":"sale","acquired":false,"shares":314,"price":95.1227,"value":29868.5278,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were sold by the reporting person to generate proceeds used to satisfy the tax withholding obligation that arose upon the vesting of certain restricted stock units granted to the reporting person on August 1, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The shares were sold in multiple transactions at prices ranging from $94.6257 to $96.0400, inclusive. The reported price reflects the weighted-average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected."}],"balance_after":815959,"source":{"system":"sec-edgar","filing":"0001209191-21-052299","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1684532/000120919121052299/doc4.xml","form_type":"4"}},{"id":2703239,"issuer":{"id":2545,"kind":"organization","name":"Fulgent Genetics, Inc.","symbol":"FLGT"},"owners":[{"id":2548,"kind":"person","name":"Gao Hanlin","position":1,"cik":"0001684532","reported_name":"Gao Hanlin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-05-20T21:27:06.000Z","date":"2021-05-18","kind":"sale","acquired":false,"shares":315,"price":70.7102,"value":22273.713,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were sold by the reporting person to generate proceeds used to satisfy the tax withholding obligation that arose upon the vesting of certain restricted stock units granted to the reporting person on August 1, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The shares were sold in multiple transactions at prices ranging from $69.61 to $71.05, inclusive. The reported price reflects the weighted-average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected."}],"balance_after":816273,"source":{"system":"sec-edgar","filing":"0001209191-21-034515","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1684532/000120919121034515/doc4.xml","form_type":"4"}},{"id":2733054,"issuer":{"id":2545,"kind":"organization","name":"Fulgent Genetics, Inc.","symbol":"FLGT"},"owners":[{"id":2548,"kind":"person","name":"Gao Hanlin","position":1,"cik":"0001684532","reported_name":"Gao Hanlin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-05-03T20:43:43.000Z","date":"2021-04-30","kind":"grant","acquired":true,"shares":3500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects an award of restricted stock units relating to 3,500 shares of the Issuer's common stock. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The shares subject to the restricted stock units vest over a period of four years, with 1/4th of such shares vesting 12 months after April 30, 2021, and 1/16th of such shares vesting every three months over the remaining 36 months, subject to the reporting person's continued service for Issuer on each vesting date."}],"balance_after":816588,"source":{"system":"sec-edgar","filing":"0001209191-21-029476","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1684532/000120919121029476/doc4.xml","form_type":"4"}},{"id":2859215,"issuer":{"id":2545,"kind":"organization","name":"Fulgent Genetics, Inc.","symbol":"FLGT"},"owners":[{"id":2548,"kind":"person","name":"Gao Hanlin","position":1,"cik":"0001684532","reported_name":"Gao Hanlin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-02-16T23:07:10.000Z","date":"2021-02-15","kind":"tax_withholding","acquired":false,"shares":303,"price":161.09,"value":48810.27,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units granted to the reporting person on August 1, 2019."}],"balance_after":813088,"source":{"system":"sec-edgar","filing":"0001209191-21-010925","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1684532/000120919121010925/doc4.xml","form_type":"4"}},{"id":2975311,"issuer":{"id":2545,"kind":"organization","name":"Fulgent Genetics, Inc.","symbol":"FLGT"},"owners":[{"id":2548,"kind":"person","name":"Gao Hanlin","position":1,"cik":"0001684532","reported_name":"Gao Hanlin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2020-11-19T00:50:29.000Z","date":"2020-11-17","kind":"sale","acquired":false,"shares":301,"price":45.4488,"value":13680.0888,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were sold by the reporting person to generate proceeds used to satisfy the tax withholding obligation that arose upon the vesting of certain restricted stock units granted to the reporting person on\nAugust 1, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The shares were sold in multiple transactions at prices ranging from $45.2512 to $45.56, inclusive. The reported price reflects the weighted-average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected."}],"balance_after":813391,"source":{"system":"sec-edgar","filing":"0001209191-20-059269","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1684532/000120919120059269/doc4.xml","form_type":"4"}},{"id":3031382,"issuer":{"id":2545,"kind":"organization","name":"Fulgent Genetics, Inc.","symbol":"FLGT"},"owners":[{"id":2548,"kind":"person","name":"Gao Hanlin","position":1,"cik":"0001684532","reported_name":"Gao Hanlin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2020-09-16T00:52:50.000Z","date":"2020-09-15","kind":"other","acquired":false,"shares":467659,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transfer was made without the receipt of consideration to a blind trust. The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for the purpose of Section 16 or for any other purpose."}],"balance_after":813692,"source":{"system":"sec-edgar","filing":"0001209191-20-050606","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1684532/000120919120050606/doc4.xml","form_type":"4"}},{"id":3052488,"issuer":{"id":2545,"kind":"organization","name":"Fulgent Genetics, Inc.","symbol":"FLGT"},"owners":[{"id":2548,"kind":"person","name":"Gao Hanlin","position":1,"cik":"0001684532","reported_name":"Gao Hanlin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2020-08-20T01:11:19.000Z","date":"2020-08-17","kind":"sale","acquired":false,"shares":1308,"price":41.1098,"value":53771.6184,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were sold by the reporting person to generate proceeds used to satisfy the tax withholding obligation that arose upon the vesting of certain restricted stock units granted to the reporting person on\nAugust 1, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The shares were sold in multiple transactions at prices ranging from $41.10 to $41.11, inclusive. The reported price reflects the weighted-average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected."}],"balance_after":1281351,"source":{"system":"sec-edgar","filing":"0001209191-20-047659","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1684532/000120919120047659/doc4.xml","form_type":"4"}},{"id":3413918,"issuer":{"id":2545,"kind":"organization","name":"Fulgent Genetics, Inc.","symbol":"FLGT"},"owners":[{"id":2548,"kind":"person","name":"Gao Hanlin","position":1,"cik":"0001684532","reported_name":"Gao Hanlin","relationship":{"director":false,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Issuer Common Stock","published_at":"2019-09-17T01:05:53.000Z","date":"2019-09-12","kind":"other","acquired":false,"shares":500000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transfer was made without the receipt of consideration to a blind trust. The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for the purpose of Section 16 or for any other purpose."}],"balance_after":1267659,"source":{"system":"sec-edgar","filing":"0001209191-19-049726","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1684532/000120919119049726/doc4.xml","form_type":"4"}}],"next_cursor":"2019-09-17T01:05:53.000000Z,3413918"}